123 related articles for article (PubMed ID: 7083219)
1. Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate.
Gadgil SD; Damle SR; Advani SH; Vaidya AB
Cancer Treat Rep; 1982 May; 66(5):1169-71. PubMed ID: 7083219
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
Breithaupt H; Küenzlen E
Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
[TBL] [Abstract][Full Text] [Related]
3. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
5. Age-related pharmacokinetics of high-dose methotrexate in patients with osteosarcoma.
Wang YM; Sutow WW; Romsdahl MM; Perez C
Cancer Treat Rep; 1979 Mar; 63(3):405-10. PubMed ID: 284845
[TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate: pharmacokinetics in children and young adults.
Raude E; Oellerich M; Weinel P; Freund M; Schrappe M; Riehm H; Poliwoda H
Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):364-70. PubMed ID: 3209285
[TBL] [Abstract][Full Text] [Related]
7. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
Brahmi N; Kouraichi N; Thabet H; Amamou M
Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
[TBL] [Abstract][Full Text] [Related]
8. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.
Isacoff WH; Morrison PF; Aroesty J; Willis KL; Block JB; Lincoln TL
Cancer Treat Rep; 1977 Dec; 61(9):1665-74. PubMed ID: 304376
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
Bleyer WA; Dedrick RL
Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
[TBL] [Abstract][Full Text] [Related]
11. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
[TBL] [Abstract][Full Text] [Related]
12. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
13. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma].
Fernández Megía MJ; Alós Almiñana M; Esquer Borrás J
Farm Hosp; 2004; 28(6):433-9. PubMed ID: 15628946
[TBL] [Abstract][Full Text] [Related]
15. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
Bremnes RM; Slørdal L; Wist E; Aarbakke J
Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
Kärkkäinen S; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate for intraocular lymphoma.
Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
[TBL] [Abstract][Full Text] [Related]
18. Effects of urine alkalization and activated charcoal on the pharmacokinetics of orally administered carprofen in dogs.
Raekallio MR; Honkavaara JM; Säkkinen MS; Peltoniemi SM
Am J Vet Res; 2007 Apr; 68(4):423-7. PubMed ID: 17397299
[TBL] [Abstract][Full Text] [Related]
19. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
[TBL] [Abstract][Full Text] [Related]
20. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
Bressolle F; Bologna C; Kinowski JM; Arcos B; Sany J; Combe B
J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
